Nathalie Delzenne is also a lecturer in Nutrition Biochemistry and Metabolism and President of the Metabolism and Nutrition Research Group at the Louvain Drug Research Institute within UCL.
Nathalie Delzenne is involved in several international scientific committees as President of the
Belgian Nutrition Society, Editor for the Current Opinion in Clinical Nutrition and Metabolism, as well
as Member of the Scientific Board of the European Society for Enteral and Parenteral Nutrition.
Meanwhile, she was also a former member of the Board of Directors of the International Scientific
Association for Probiotics and Prebiotics.
After obtaining a PhD in Pharmaceutical sciences in 1991 and a post-doctoral certificate in Nutrition
(Lausanne, CH), she performed post-doctoral research related to nutrient-gene interactions (Paris
Inserm Unit 342).
Following this, Nathalie Delzenne returned to the Université Catholique de Louvain, where she
started an academic career. She pioneered the discovery of nutrients (prebiotics) and the
importance of their role in controlling malnutrition (obesity, cachexia, polyunsaturated fatty acid
deficiencies, etc.) and similar metabolic disorders.
She has published as either first or last author more than 250 papers and she currently leads several
international projects that are focused on nutrition and health. Nathalie Delzenne is also President
of the Louvain Drug Research institute.
Projects with KitoZyme
The Adipostop project aims at developing a synergistic and innovative combination of ingredients to
fight against the development of cardiovascular diseases. The nutritional approach is oriented
towards emerging cardiovascular risk factors and the relationships that may exist between the
modulation of gut microbiota and the prevention of cardiovascular diseases.
The FiberTAG project will establish a set of biomarkers for dietary fiber binding (DF) and the gut-
microbiota related health effect. We are aiming to refine the concept of DF based on microbiota-
nutrient interaction by using existing cohorts and developing innovative approaches to evaluate
Publications with KitoZyme